Peculiarities of stroke risk in women

Cerebrovascular Diseases

Volumn 24, Issue SUPPL. 1, 2007, Pages 76-83

  Egido, Jose Antonio ^a   Alonso De Leciñana, María ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Atherosclerosis; Estrogens; Hormone replacement therapy; Ischemic stroke; Risk factors

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; GESTAGEN;

ATHEROGENESIS; BIRTH; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONFERENCE PAPER; DRUG MEGADOSE; FEMALE; FEMALE FERTILITY; FERTILE PERIOD; FIBROMUSCULAR DYSPLASIA; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MENOPAUSE; MIGRAINE; NEUROPROTECTION; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ESTROGENS; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; STROKE; WOMEN'S HEALTH;

EID: 35649027841     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107381     Document Type: Conference Paper

References (76)

1. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
2. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria. Incidence, recurrence and long-term survival in ischemic stroke subtypes: a population based study. Stroke 2001;32:2735-2740.
3. Amantea D, Russo R, Bagetta G, Corasiniti MT: From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res 2005;52:119-132.
4. Di Carlo A, Launer LJ, Breteler MM, Fratiglioni L, Lobo A, Martinez-Lage J, Schmidt R, Hofman A: Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology 2000;54(suppl 5):S28-S33.
5. The World Health Report 2003: shaping the future. World Health Organization. www.who.int/whr/2003/en/.
6. Instituto Nacional de Estadística: Defunciones según la causa de muerte 2004. www.ine.es, 30 diciembre 2004.
7. Morín Martín MM, González Santiago R, Gil Nuñez AC, Vivancos Mora J: Women and stroke. Hospital epidemiology in Spain. Rev Neurol 2003;37:701-705.
8. Arboix A, Olivares M, García-Eroles L, Maragall C, Massons J, Targa C: Acute cerebrovascular disease in women. Eur Neurol 2001;45:199-205.
9. Roquer J, Campello AR, Gomis M: Sex differences in first-ever acute stroke. Stroke 2003;34:1581-1585.
10. Prencipe M, Ferretti C, Casini AR, Santini M, Giubilei F, Culasso F: Stroke, disability, and dementia: results of a population survey. Stroke 1997;28:531-536.
11. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996;27:373-380.
12. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA: Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998;147:259-268.
13. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, Wityk RJ, Wozniak MA: Pregnancy and the risk of stroke: N Engl J Med 1996;335:768-774.
14. Brey RL, Stallworth CL, McGlasson DL, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, Macko RF, Johnson CJ, Earley CJ, Buchholz DW, Hebel JR, Kittner SJ: Antiphospholipid antibodies and stroke in young women. Stroke 2002;33:2396-2400.
15. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E: Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association Writing Group. Circulation 1997;96:2468-2482.
16. Moulin T, Tatu L, Vuillier F, Berger E, Chavot D, Rumbach L: Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcome of 1,776 consecutive patients from the Besançon stroke registry. Cerebrovasc Dis 2000;10:261-271.
17. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC: Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001;32:2559-2566.
18. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 1999;30:2513-2516.
19. World Health Organization: WHO Global Infobase. http://www.who.int/ ncd_surveillance/infobase/web/InfoBaseCommon/.
20. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183.
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
22. Summary of the second report on the National Cholesterol Education Program (NCEP). Expert Panel on detection evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
23. Kurth T, Gaziano JM, Rexrode KM, Kase CS, Cook NR, Manson JE, Buring JE: Prospective study of body mass index and risk of stroke in apparently healthy women. Circulation 2005;111:1992-1998.
24. Sanchez-Sanchez C, Egido JA, Gonzalez-Gutierrez JL, Mera-Campillo J, Carneado-Ruiz J, Diaz-Otero F: Stroke and intracranial stenosis: clinical profile in a series of 134 patients in Spain. Rev Neurol 2004;39:305-311.
25. Bousser MG: Estrogens, migraine and stroke. Stroke 2004;35(suppl 1):2652-2656.
26. Etminan M, Takkouche B, Isorna FC, Samii A: Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63-66.
27. Gillum LA, Mamidipudi SK, Johnston SC: Ischemic stroke risk with oral contraceptives: a meta-analysis. JAMA 2000;284:72-78.
28. Alonso de Leciñana M, Egido JA: Estrogens as neuroprotectants against ischemic stroke. Cerebrovasc Dis 2006;21(suppl 2):48-53.
29. Bath PM, Gray LJ: Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005;330:342-345
30. Mosca L, Collins P, Herrington DM, et al: Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001;104:499-503.
31. Chang CL, Donaghy M, Poulter N: Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999;318:13-18.
32. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ: Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
33. Friberg L, Olsen TS, Roland PE, Lassen NA: Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study. Brain 1987;110:917-934.
34. Crassard I, Conard J, Bousser MG: Migraine and haemostasis. Cephalalgia 2001;21:630-636.
35. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE: Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 1994;343:940-943.
36. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G: Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999;52:1622-1625.
37. Bushnell CD: Oestrogen and stroke in women: assessment of risk. Lancet Neurol 2005;4:743-751.
38. Chan WS, Ray J, Wai EK, Ginsburg S, Hannah ME, Corey PN, Ginsberg JS: Risk of stroke in women exposed to low-dose oral contraceptives: a critical evaluation of the evidence. Arch Intern Med 2004;164:741-747.
39. Kemmeren JM, Tanis BC, van den Bosch MA, Bollen EL, Helmerhorst FM, van der Graaf Y, Rosendaal FR, Algra A: Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002;33:1202-1208.
40. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL: Primary prevention of ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council. Stroke 2006;37:1583-1633.
41. James AH, Bushnell CD, Jamison MG, Myers ER: Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005;106:509-516.
42. Sharshar T, Lamy C, Mas JL: Incidence and causes of stroke associated with pregnancy and puerperium. A study in public hospitals in IIe de France. Stroke in Pregnancy Study Group. Stroke 1995;26:930-936.
43. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, Wityk RJ, Wozniak MA: Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-774.
44. Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E: Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006;21:271-276.
45. Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J: Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke 2005;36:e53-e55.
46. Elford K, Leader A, Wee R, Stys PK: Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA. Neurology 2002;59:1270-1272.
47. Mendez JC, Masjuan J, Garcia N, Alonso de Leciñana M: Successful intra-arterial thrombolysis for acute ischemic stroke in the immediate postpartum period: case report. Cardiovasc Intervent Radiol 2006;DOI: 10.1007/s00270-006-0033-8. E-pub ahead of print.
48. Lamy C, Hamon JB, Coste J, Mas JL: Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology 2000;55:269-274.
49. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ: Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006;37:1055-1056.
50. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WC: Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:845.
51. Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D: Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol 1995;142:1011-1019.
52. Akkad A, Harsthorne T, Bell PR, al Azzawi F: Carotid plaque regression on oestrogen replacement: a pilot study. Eur J Vasc Endovasc Surg 1996;11:347-348.
53. Petitti DB, Sidney S, Quesenberry CP, Bernstein A: Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998;29:23-28.
54. Hulley S, Grady D, Bush T, et al, HERS Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-613.
55. Simon JA, Hsia J, Cauley JA, et al: Postmenopausal hormone therapy and risk of stroke. The Heart and Estrogen-Progestin Replacement Study (HERS). Circulation 2001;103:638-642.
56. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI: A clinical trial of estrogen replacement after ischemic stroke. N Engl J Med 2001;345:1243-1249.
57. Rossouw JE, Anderson GL, Prentice RL, et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
58. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD: Postmenopausal hormone replacement therapy. Scientific review. JAMA 2002;288:872-881.
59. Bath PM, Gray LJ: Association between hormone replacement therapy and subsequent stroke: a meta-analysis. Br Med J 2005;330:342-345.
60. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T: Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006;37:577-617.
61. Alonso de Leciñana M, Egido JA, Fernández C, Martínez-Vila E, Mostacero E, Morales A, Gil-Peralta A, Pareja A, Álvarez-Sabín J, Casado I, on behalf of the PIVE Study Investigators of the Stroke Project of the Spanish Cerebrovascular Diseases Study Group: Risk of ischemic stroke and lifetime estrogen exposure. Neurology 2007;68:33-38.
62. 2 receptor density and aggregation responses. Circulation 1995;91:2742-2747.
63. Feuring M, Christ M, Roell A, Schueller P, Losel R, Dempfle CE, Schultz A, Wehling M: Alterations in platelet function during the ovarian cycle. Blood Coagul Fibrinolysis 2002;13:443-447.
64. Emms H, Lewis GP: Sex and hormonal influences on platelet sensitivity and coagulation in the rat. Br J Pharmacol 1985;86:557-563.
65. Montgomery PR, Berger LG, Mitenko PA, Sitar DS: Salicylate metabolism: effects of age and sex in adults. Clin Pharmacol Ther 1986;39:571-576.
66. Ridker PM, Hennekens CH, Tofler GH, Lipinska I, Buring JE: Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women. J Cardiovasc Risk 1996;3:209-212.
67. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
68. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH: An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003;163:2006-2010.
69. Ricker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-1304.
70. Hayden M, Pignone M, Phillips C, Mulrow C: Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;136:161-172.
71. Bates SM, Greer IA, Hirsh J, Ginsberg JS: Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(suppl):627S-644S.
72. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ, Carotid Endarterectomy Trialists Collaboration: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;363:915-924.
73. Rothwell PM: ACST: which subgroups will benefit most from carotid endarterectomy? Lancet 2004;364:1122-1123.
74. Chambers BR, Donnan GA: Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005;4:CD001923.
75. Bond R, Rerkasem K, Cuffe R, Rothwell PM: A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis 2005;20:69-77.
76. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP: Treating individuals. 3. From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet 2005;365:256-265.